EP Patent

EP2270018A1 — Antitumoral analogs

Assigned to Pharmamar SA · Expires 2011-01-05 · 15y expired

What this patent protects

Derivatives of ecteinascidin 736 are provided.

USPTO Abstract

Derivatives of ecteinascidin 736 are provided.

Drugs covered by this patent

Patent Metadata

Patent number
EP2270018A1
Jurisdiction
EP
Classification
—
Expires
2011-01-05
Drug substance claim
No
Drug product claim
No
Assignee
Pharmamar SA
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.